Table 3 Perioperative outcomes of RAPN versus OPN
Study (OPN/RAPN) | OT (min) | WIT (min) | MBL (ml) | Positive margins (%) | HS (day) | eGFR change (ml/min per 1.73 m2) | Transfusion rate (%) | Conversion rate (%) |
|---|---|---|---|---|---|---|---|---|
Wu et al. [10] | NA/NA | NA/NA | NA/NA | 0 (0.0)/0 (0.0) | NA/NA | NA/NA | 4 (4.3)/3 (5.9) | 1 (1.1)/0 (0.0) |
Vittori et al. [11] | 123 ± 43/168 ± 56 | 18.7 ± 8.1/18.2 ± 7 | 230 ± 208/125 ± 128 | 11 (5.6)/6 (5.7) | NA/NA | NA/NA | NA/NA | 2 (1.0)/1 (0.9) |
Masson-Lecomte et al. [16] | 128.4 ± 50.5/134.8 ± 35.3 | 17.1 ± 5.9/17.5 ± 7.8 | 414.7 ± 367.5/142.9 ± 225.9 | 4 (6.9)/1 (2.4) | 6.8 ± 3.5/3.8 ± 1.1 | NA/NA | NA/NA | NA/NA |
Ficarra et al. [17] | NA/NA | NA/NA | NA/NA | 9 (4.5)/9 (4.5) | NA/NA | −16.6 ± 18.1/−16.4 ± 22.9 | 20 (10.0)/21 (10.5) | NA/NA |
Kim et al. [24] | 126.8 ± 42.7/196.9 ± 50.1 | 27.8 ± 9.7/31.3 ± 9.5 | 356.7 ± 269.2/296.8 ± 246.8 | 1 (1.2)/2 (3.0) | 4.6 ± 2.1/2.9 ± 1.4 | −0.49 ± 17.5/−2.54 ± 16.01 | 13 (15.7)/5 (7.5) | 7 (8.4)/4 (5.9) |
Lucas et al. [18] | NA/NA | NA/NA | NA/NA | 4 (7.4)/1 (3.7) | NA/NA | NA/NA | NA/NA | 0 (0.0)/1 (3.7) |
Han et al. [6] | 187.2 ± 43.8/162.3 ± 32.3 | 19.6 ± 6.7/24.7 ± 7.3 | NA/NA | NA/NA | 7.3 ± 2.06/5.3 ± 1.41 | −4.34 ± 8.34/−2.4 ± 6.7 | NA/NA | NA/NA |
Oh et al. [19] | 138.79 ± 40.29/182.89 ± 83.98 | 21.18 ± 11.29/21.86 ± 9.25 | 230.74 ± 159.33/212.04 ± 160.76 | 1 (1.0)/0 (0.0) | 9.26 ± 3.22/5.41 ± 1.84 | −6.19 ± 7.32/−7.53 ± 4.28 | 6 (6.0)/4 (4.0) | NA/NA |
Lee et al. [9] | 142.77 ± 47.69/192.42 ± 78.05 | 18.14 ± 7.16/22.99 ± 8.43 | 216.50 ± 165.38/228.70 ± 182.89 | 6 (2.6)/0 (0.0) | 8.90 ± 3.11/6.20 ± 1.99 | −5.25 ± 10.01/−6.11 ± 9.14 | NA/NA | 1 (0.4)/1 (1.4) |
Alemozaffar et al. [7] | 238.3 ± 119.5/231.8 ± 44.2 | NA/NA | 275.4 ± 170.0/178.0 ± 205.7 | NA/NA | 4.60 ± 1.68/2.48 ± 0.68 | NA/NA | NA/NA | NA/NA |
Simhan et al. 1 2012 [12] | 189.5 ± 52.0/205.9 ± 52.5 | NA/NA | 256.5 ± 291.3/131.3 ± 127.8 | 1 (0.7)/3 (3.7) | 5.6 ± 3.9/3.7 ± 1.6 | 1.5 ± 21/−2.4 ± 23.1 | NA/NA | NA/NA |
Simhan et al. 2 2012 [12] | 197.5 ± 60.4/221.1 ± 72.5 | NA/NA | 330.6 ± 406.0/225.0 ± 304 | 3 (5.6)/0 (0.0) | 6.1 ± 4.1/2.9 ± 1.4 | 6.1 ± 25.2/−9 ± 21.2 | NA/NA | NA/NA |
Zargar et al. 1 2014 [20] | 185.42 ± 5 6.4/174.9 ± 61.7 | NA/NA | NA/NA | 3 (9.1)/2 (6.7) | NA/NA | NA/NA | 5 (15.2)/6 (20.0) | NA/NA |
Zargar et al. 2 2014 [20] | 244.1 ± 59.3/250.8 ± 66 | 23.9 ± 8.1/22.7 ± 5.8 | NA/NA | 4 (7.7)/1 (10.0) | NA/NA | NA/NA | 8 (15.4)/0 (0.0) | NA/NA |
Boylu et al. [8] | 152 ± 18/225 ± 58 | 18 ± 3.5/23 ± 7.3 | 417 ± 202/268 ± 303 | 0 (0.0)/1 (2.1) | 5.4 ± 2/4.11 ± 1.5 | NA/NA | 2 (10.0)/5 (10.9) | NA/NA |
Mano et al. [22] | 128 (108–156)/154 (113–177)b | NA/NA | 200 (100–413)/100 (25–200)b | NA/NA | 2.47 ± 1.31/1.51 ± 0.76 | NA/NA | NA/NA | NA/NA |
Miyake et al. [23] | 203.7 ± 55.2/263.0 ± 63.5 | 20.3 ± 9.1/23.0 ± 7.5(1) | 653.6 ± 611.7/57.5 ± 96.9 | 0 (0)/0 (0) | 4.8 ± 0.8/4.2 ± 0.8 | 10.0 ± 6.6/10.4 ± 7.0 | 0 (0)/0 (0) | 0 (0)/0 (0) |
Webb et al. [21] | NA/NA | 30.69 ± 10.65a/28.01 ± 9.34 | NA/NA | 1 (4.8)/1 (7.1) | 4 (3–6)b/3 (2–4)b | NA/NA | 0 (0)/0 (0) | 2 (9.5)/0 (0) |